BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31039468)

  • 41. Radiotherapy trial quality assurance processes: a systematic review.
    Brooks C; Miles E; Hoskin PJ
    Lancet Oncol; 2024 Mar; 25(3):e104-e113. PubMed ID: 38423056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.
    Gwynne S; Spezi E; Sebag-Montefiore D; Mukherjee S; Miles E; Conibear J; Staffurth J;
    Br J Radiol; 2013 Apr; 86(1024):20120398. PubMed ID: 23392188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review.
    Fairchild A; Straube W; Laurie F; Followill D
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):246-60. PubMed ID: 23683829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours.
    Lambrecht M; Sonke JJ; Nestle U; Peulen H; Weber DC; Verheij M; Hurkmans CW
    Phys Imaging Radiat Oncol; 2018 Oct; 8():57-62. PubMed ID: 33458418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructure.
    Gwynne S; Jones G; Maggs R; Eaton D; Miles E; Staffurth J; Nixon L; Ray R; Lewis G; Crosby T; Spezi E
    Br J Radiol; 2016 Aug; 89(1064):20160020. PubMed ID: 27245136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the introduction of weekly radiotherapy quality assurance meetings at one UK cancer centre.
    Brammer CV; Pettit L; Allerton R; Churn M; Joseph M; Koh P; Sayers I; King M
    Br J Radiol; 2014 Nov; 87(1043):20140422. PubMed ID: 25251520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.
    Willett CG; Moughan J; O'Meara E; Galvin JM; Crane CH; Winter K; Manfredi D; Rich TA; Rabinovitch R; Lustig R; Machtay M; Curran WJ
    Radiother Oncol; 2012 Oct; 105(1):9-13. PubMed ID: 23084596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
    Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Weber DC; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Obrecht D; Rutkowski S; Timmermann B; Kortmann RD
    Strahlenther Onkol; 2022 Mar; 198(3):282-290. PubMed ID: 34351451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of reporting on thoracic radiotherapy technique in prospective lung cancer trials: A systematic review.
    Soon YY; Chen D; Tan TH; Seong Tey JC
    Medicine (Baltimore); 2019 Jun; 98(26):e16124. PubMed ID: 31261531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Driving developments in UK oesophageal radiotherapy through the SCOPE trials.
    Gwynne S; Higgins E; Poon King A; Radhakrishna G; Wills L; Mukherjee S; Hawkins M; Jones G; Staffurth J; Crosby T
    Radiat Oncol; 2019 Feb; 14(1):26. PubMed ID: 30717810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality Assurance in Radiotherapy (RT)-Specific Trials: Indian Scenario.
    Mahata A; Chakraborty S; Mandal S; Achari RB; Bhattacharyya T; Mallick I; Arunsingh M; Chatterjee S
    Clin Oncol (R Coll Radiol); 2024 Jun; ():. PubMed ID: 38897901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quality assurance of radiotherapy in clinical research].
    Lisbona A; Llagostera C
    Cancer Radiother; 2022 Oct; 26(6-7):814-817. PubMed ID: 36050203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basic concepts and directions in the radiation therapy quality assurance processes of clinical trials.
    Thariat J; Loiseau C
    Cancer Radiother; 2023 Sep; 27(6-7):464-468. PubMed ID: 37541796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corrigendum to 'Assessment of deep learning-based auto-contouring on interobserver consistency in target volume and organs-at-risk delineation for breast cancer: Implications for RTQA program in a multi-institutional study' [The Breast 73 (2024) 103599].
    Choi MS; Chang JS; Kim K; Kim JH; Kim TH; Kim S; Cha H; Cho O; Choi JH; Kim M; Kim J; Kim TG; Yeo SG; Chang AR; Ahn SJ; Choi J; Kang KM; Kwon J; Koo T; Kim MY; Choi SH; Jeong BK; Jang BS; Jo IY; Lee H; Kim N; Park HJ; Im JH; Lee SW; Cho Y; Lee SY; Chang JH; Chun J; Lee EM; Kim JS; Shin KH; Kim YB
    Breast; 2024 Apr; 74():103624. PubMed ID: 38161095
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment and classification of protocol deviations.
    Ghooi RB; Bhosale N; Wadhwani R; Divate P; Divate U
    Perspect Clin Res; 2016; 7(3):132-6. PubMed ID: 27453830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience.
    Turcas A; Kelly SM; Bernier-Chastagner V; Bolle S; Cameron A; Corning C; Clementel E; Dieckmann K; Davila Fajardo R; Gaze MN; Laprie A; Magelssen H; Meroni S; Pignoli E; Safwat A; Scarzello G; Talbot J; Timmermann B; Boterberg T; Mandeville HC
    Radiother Oncol; 2023 Oct; 187():109810. PubMed ID: 37468069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benchmarking Protocol Deviations and Their Variation by Major Disease Categories.
    Getz K; Smith Z; Jain A; Krauss R
    Ther Innov Regul Sci; 2022 Jul; 56(4):632-636. PubMed ID: 35378712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of Radiation Therapy Treatment Deviations by a Novel Combined Biometric, Radiofrequency Identification, and Surface Imaging System.
    Zhao H; Paxton A; Sarkar V; Huang YJ; Frances Su FC; Haacke C; Rassiah-Szegedi P; Szegedi M; Salter B
    Pract Radiat Oncol; 2021; 11(2):e229-e235. PubMed ID: 32919040
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.